HRP20090187T1 - Bengamide derivatives and use thereof for the treatment of cancer - Google Patents

Bengamide derivatives and use thereof for the treatment of cancer

Info

Publication number
HRP20090187T1
HRP20090187T1 HR20090187T HRP20090187T HRP20090187T1 HR P20090187 T1 HRP20090187 T1 HR P20090187T1 HR 20090187 T HR20090187 T HR 20090187T HR P20090187 T HRP20090187 T HR P20090187T HR P20090187 T1 HRP20090187 T1 HR P20090187T1
Authority
HR
Croatia
Prior art keywords
cancer
treatment
bengamide derivatives
bengamide
derivatives
Prior art date
Application number
HR20090187T
Other languages
Croatian (hr)
Inventor
Hoffmann Holger
Haag-Richter Sabine
Kurz Michael
Tietgen Heiko
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20090187T1 publication Critical patent/HRP20090187T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Abstract

Spoj formule (I), gdje R1 jest H ili (C1-C6)-alkilR2 jest H ili OH, iR3 jest H ili -C(=O)-(C1-C6)-alkil, ili njegova fiziološki podnošljiva sol. Patent sadrži još 9 patentnih zahtjeva.A compound of formula (I), wherein R 1 is H or (C 1 -C 6) -alkylR 2 is H or OH, and R 3 is H or -C (= O) - (C 1 -C 6) -alkyl, or a physiologically tolerable salt thereof. The patent contains 9 more patent claims.

HR20090187T 2003-10-24 2009-03-31 Bengamide derivatives and use thereof for the treatment of cancer HRP20090187T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10349669A DE10349669B3 (en) 2003-10-24 2003-10-24 Bengamide derivatives, process for their preparation and their use
PCT/EP2004/011244 WO2005044803A1 (en) 2003-10-24 2004-10-08 Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer

Publications (1)

Publication Number Publication Date
HRP20090187T1 true HRP20090187T1 (en) 2009-05-31

Family

ID=34484998

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090187T HRP20090187T1 (en) 2003-10-24 2009-03-31 Bengamide derivatives and use thereof for the treatment of cancer

Country Status (30)

Country Link
EP (2) EP1873146B1 (en)
JP (1) JP4769190B2 (en)
KR (1) KR20060120044A (en)
CN (2) CN100398520C (en)
AR (1) AR046553A1 (en)
AT (2) ATE420074T1 (en)
AU (1) AU2004287561B2 (en)
BR (1) BRPI0415529A (en)
CA (1) CA2543003A1 (en)
CL (1) CL2009000674A1 (en)
CY (1) CY1110458T1 (en)
DE (3) DE10349669B3 (en)
DK (1) DK1680405T3 (en)
ES (1) ES2320894T3 (en)
HK (1) HK1098131A1 (en)
HR (1) HRP20090187T1 (en)
IL (1) IL174524A (en)
MA (1) MA28213A1 (en)
ME (1) MEP33108A (en)
MX (1) MXPA06004084A (en)
NO (1) NO20062149L (en)
NZ (1) NZ546744A (en)
PL (1) PL1680405T3 (en)
PT (1) PT1680405E (en)
RS (1) RS20060263A (en)
RU (1) RU2357956C2 (en)
SI (1) SI1680405T1 (en)
UY (1) UY28574A1 (en)
WO (1) WO2005044803A1 (en)
ZA (1) ZA200602231B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2878528B1 (en) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDES, PREPARATION THEREOF, COMPOSITIONS CONTAINING SAME AND USE THEREOF
FR2878525B1 (en) * 2004-11-29 2007-02-23 Aventis Pharma Sa BENGAMIDES HAVING SUBSTITUTED CAPROLACTAM CYCLE, PREPARATION METHOD, COMPOSITIONS CONTAINING SAME AND USE THEREOF
FR2901556A1 (en) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDE DERIVATIVES, THEIR PREPARATION, COMPOSITIONS CONTAINING SAME AND USE THEREOF
FR2901555A1 (en) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDE-BENZOTHIAZEPINE, THEIR PREPARATION, COMPOSITIONS CONTAINING SAME AND USE THEREOF
FR2901554B1 (en) 2006-05-24 2011-04-01 Sanofi Aventis 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDE-BENZAZEPINE, PREPARATION THEREOF, COMPOSITIONS CONTAINING SAME AND USE THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5140099A1 (en) * 1998-11-17 2002-03-22 Novartis Ag CERTAIN SUBSTITUTED CAPROLACTAMAS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND ITS USE IN TUMORS TREATMENT
AU2001295206A1 (en) * 2000-05-11 2001-11-20 Novartis Ag Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
JP2004262793A (en) * 2003-02-28 2004-09-24 Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai Compound n-9011, its production method and use
CA2533335A1 (en) * 2003-07-25 2005-02-17 Novartis Ag Substituted lactams and their use as anti-cancer agents

Also Published As

Publication number Publication date
UY28574A1 (en) 2005-05-31
NZ546744A (en) 2009-03-31
EP1873146A2 (en) 2008-01-02
RS20060263A (en) 2008-09-29
NO20062149L (en) 2006-07-11
ES2320894T3 (en) 2009-05-29
AR046553A1 (en) 2005-12-14
EP1680405B1 (en) 2009-01-07
CN100398520C (en) 2008-07-02
CN1871217A (en) 2006-11-29
DE10349669B3 (en) 2005-05-25
CN101294173A (en) 2008-10-29
PT1680405E (en) 2009-03-31
DE502004008837D1 (en) 2009-02-26
WO2005044803A1 (en) 2005-05-19
EP1873146A3 (en) 2008-05-21
IL174524A0 (en) 2006-08-01
SI1680405T1 (en) 2009-06-30
CY1110458T1 (en) 2015-04-29
EP1873146B1 (en) 2010-08-11
JP2007509084A (en) 2007-04-12
HK1098131A1 (en) 2007-07-13
ZA200602231B (en) 2007-06-27
AU2004287561B2 (en) 2011-06-02
DK1680405T3 (en) 2009-05-04
KR20060120044A (en) 2006-11-24
CL2009000674A1 (en) 2009-08-07
RU2006117769A (en) 2007-11-27
BRPI0415529A (en) 2006-12-26
MA28213A1 (en) 2006-10-02
DE502004011536D1 (en) 2010-09-23
JP4769190B2 (en) 2011-09-07
CA2543003A1 (en) 2005-05-19
RU2357956C2 (en) 2009-06-10
AU2004287561A1 (en) 2005-05-19
MXPA06004084A (en) 2006-06-27
MEP33108A (en) 2010-10-10
EP1680405A1 (en) 2006-07-19
PL1680405T3 (en) 2009-06-30
ATE477244T1 (en) 2010-08-15
IL174524A (en) 2012-08-30
ATE420074T1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
FR17C0003I1 (en) STEROIDS AS FXR AGONISTS
RS52625B (en) Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
DK1558579T3 (en) N-alkyl-4-methylenamino-3-hydroxy-2-pyridones as antimicrobials
NO20054476L (en) Compounds for the treatment of pain
GB0127903D0 (en) Improvements relating to organic compounds
CY1106247T1 (en) THIOPHEN- AND THIAZOLESULFONAMIDES AS ANTINEOPLASTIC AGENTS
DK1177176T3 (en) Triarylic acid derivatives as PPAR receptor ligands
HRP20030383B1 (en) Lactam compound
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
HRP20090187T1 (en) Bengamide derivatives and use thereof for the treatment of cancer
HK1081194A1 (en) 6-amino-1h-indazole compounds as phosphodiesterase4 inhibitors, pharmaceutical compositions compris ing the same, and use thereof
BR0205812A (en) Benzimidazoles Useful in the Treatment of Sexual Dysfunction
AU2003294082A1 (en) Composition comprising a carbamic acid derivative, its use as cosmetic and medicine
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
MX2008001778A (en) Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof.
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
BR0305708A (en) Benzimidazole derivatives for the treatment of sexual dysfunction
TR200302288T2 (en) New compounds and methods for therapy.
DK1204658T3 (en) Benzofurylpiperazine-serotonin agonists
MXPA06003345A (en) Aminopyridine-derivatives as inductible no-synthase inhibitors.
MXPA03008248A (en) N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives.
NO20041671L (en) Anthelmintic composition